Original Query: ALL
Previous Study | Return to List | Next Study

Cabozantinib in Advanced Pancreatic Neuroendocrine and Carcinoid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01466036
Recruitment Status : Active, not recruiting
First Posted : November 7, 2011
Last Update Posted : April 18, 2017
Information provided by (Responsible Party):
Janet Elaine Murphy, Massachusetts General Hospital

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : October 2018
  Estimated Study Completion Date : April 2022